NCT05172596
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05172596
Title PHE885 CAR-T Therapy in Adult Participants With Relapsed and Refractory Multiple Myeloma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | ISR | GRC | GBR | FRA | ESP | DEU | CAN | BRA | AUS

Facility Status City State Zip Country Details
Stanford University Palo Alto California 94304 United States Details
Emory University School of Medicine-Winship Cancer Institute Atlanta Georgia 30322 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Oregon Health Sciences University Portland Oregon 97239 United States Details
Thomas Jefferson University Philadelphia Pennsylvania 19107 United States Details
Fred Hutch Cancer Research Seattle Washington 98109 United States Details
Novartis Investigative Site Camperdown New South Wales 2050 Australia Details
Novartis Investigative Site Melbourne Victoria 3004 Australia Details
Novartis Investigative Site Salvador Estado de Bahia 41253-190 Brazil Details
Novartis Investigative Site São Paulo São Paulo 01509-900 Brazil Details
Novartis Investigative Site Calgary Alberta T2N 5G2 Canada Details
Novartis Investigative Site Lille 59037 France Details
Novartis Investigative Site Nantes 44093 France Details
Novartis Investigative Site Paris 75475 France Details
Novartis Investigative Site Poitiers 86021 France Details
Novartis Investigative Site Würzburg Bavaria 97080 Germany Details
Novartis Investigative Site Cologne North Rhine-Westphalia 50937 Germany Details
Novartis Investigative Site Hamburg 20246 Germany Details
Novartis Investigative Site Heidelberg 69120 Germany Details
Novartis Investigative Site Athens 106 76 Greece Details
Novartis Investigative Site Thessaloniki 570 10 Greece Details
Novartis Investigative Site Ramat Gan 5265601 Israel Details
Novartis Investigative Site Tel Aviv 6423906 Israel Details
Novartis Investigative Site Bologna BO 40138 Italy Details
Novartis Investigative Site Milan MI 20133 Italy Details
Novartis Investigative Site Nagoya Aichi-ken 4678602 Japan Details
Novartis Investigative Site Sapporo Hokkaido 060 8648 Japan Details
Novartis Investigative Site Kyoto Kyoto 602-8566 Japan Details
Novartis Investigative Site Sendai Miyagi 980 8574 Japan Details
Novartis Investigative Site Riyadh 11211 Saudi Arabia Details
Novartis Investigative Site Singapore 119074 Singapore Details
Novartis Investigative Site Singapore 169608 Singapore Details
Novartis Investigative Site Pamplona Navarre 31008 Spain Details
Novartis Investigative Site Salamanca 37007 Spain Details
Novartis Investigative Site Glasgow Scotland G51 4TF United Kingdom Details
Novartis Investigative Site Birmingham West Midlands B15 2TH United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field